Los Angeles Capital Management LLC lowered its stake in shares of Amdocs Limited (NASDAQ:DOX – Free Report) by 22.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 55,347 shares of the technology company’s stock after selling 15,926 shares during the period. Los Angeles Capital Management LLC’s holdings in Amdocs were worth $4,864,000 at the end of the most recent reporting period.
A number of other large investors have also recently made changes to their positions in the stock. GAMMA Investing LLC bought a new position in Amdocs in the 4th quarter valued at $25,000. Operose Advisors LLC boosted its stake in Amdocs by 148.0% during the third quarter. Operose Advisors LLC now owns 310 shares of the technology company’s stock valued at $26,000 after buying an additional 185 shares during the period. Oakworth Capital Inc. purchased a new position in Amdocs during the fourth quarter worth about $26,000. VisionPoint Advisory Group LLC raised its holdings in shares of Amdocs by 77.7% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 503 shares of the technology company’s stock valued at $42,000 after acquiring an additional 220 shares in the last quarter. Finally, Allworth Financial LP boosted its position in shares of Amdocs by 16,840.0% during the 3rd quarter. Allworth Financial LP now owns 847 shares of the technology company’s stock valued at $72,000 after acquiring an additional 842 shares during the last quarter. 92.02% of the stock is owned by institutional investors.
Amdocs Price Performance
DOX stock opened at $83.90 on Monday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.29 and a current ratio of 1.29. The firm has a market cap of $9.86 billion, a P/E ratio of 17.97, a P/E/G ratio of 1.36 and a beta of 0.70. The firm’s fifty day moving average is $88.95 and its 200 day moving average is $87.47. Amdocs Limited has a 52 week low of $78.38 and a 52 week high of $99.75.
Amdocs Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, April 26th. Stockholders of record on Friday, March 29th were issued a dividend of $0.479 per share. This is a positive change from Amdocs’s previous quarterly dividend of $0.44. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.28%. The ex-dividend date of this dividend was Wednesday, March 27th. Amdocs’s dividend payout ratio is currently 41.11%.
Analyst Ratings Changes
A number of brokerages recently weighed in on DOX. Citigroup raised their target price on shares of Amdocs from $96.00 to $104.00 and gave the company a “buy” rating in a research note on Wednesday, January 17th. Barclays upped their target price on shares of Amdocs from $105.00 to $115.00 and gave the stock an “overweight” rating in a research report on Thursday, February 8th. Finally, StockNews.com lowered Amdocs from a “strong-buy” rating to a “buy” rating in a research note on Friday, March 15th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, Amdocs has a consensus rating of “Buy” and an average price target of $108.60.
Check Out Our Latest Report on DOX
Amdocs Profile
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Featured Stories
- Five stocks we like better than Amdocs
- What Do S&P 500 Stocks Tell Investors About the Market?
- 3 Metal Stocks Setting Up for Double-Digit Growth
- How to Invest in Biotech Stocks
- Brinker International Heats Up on Spicy Earnings Beat and Raise
- Want to Profit on the Downtrend? Downtrends, Explained.
- Eli Lilly Gains on the GLP-1 Weight Loss Phenomenon
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.